{"product_id":"intensive-review-of-nephrology-2024","title":"Intensive Review of Nephrology 2024","description":"\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-control-plaintext\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cbr\u003e\u003cbr\u003eOakstone Intensive Review of Nephrology 2024\u003cbr\u003e\u003cbr\u003eComprehensive Nephrology CME: Clinical Update and Board Prep\u003cbr\u003e\u003cbr\u003eCase-based lectures in this acclaimed online video CME program — including board exam preparation and test-taking skills — span all areas of nephrology and feature nationally renowned speakers who are experts in their respective fields.\u003cbr\u003e\u003cbr\u003e\u003cem\u003eIntensive Review of Nephrology\u003c\/em\u003e is a practical and comprehensive review of state-of-the-art renal medicine, including diagnosis, treatment, patient care, and complex cases. Continuing medical education highlights include:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eGenetic testing for improved prognosis and therapy selection\u003c\/li\u003e\n\u003cli\u003eIntroduction to point-of-care ultrasound: fundamentals for optimal image acquisition and accurate interpretation\u003c\/li\u003e\n\u003cli\u003ePhysical exam of the dialysis access\u003c\/li\u003e\n\u003cli\u003eFurther expansion of the roles of SGLT2i and finerenone in diabetic and non-diabetic kidney disease\u003c\/li\u003e\n\u003cli\u003eCases in cryptonephrology\u003c\/li\u003e\n\u003cli\u003eThe new fundamentals in immunology and pathogenesis of glomerulonephritis\u003c\/li\u003e\n\u003cli\u003eAnd more…\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cstrong\u003eDate of Original Release:\u003c\/strong\u003e November 15, 2024\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eEstimated Time to Complete the Activity:\u003c\/strong\u003e 51.00 hours\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eLearning Objectives\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003eUpon completion of this activity, participants will be able to:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eSummarize current\/recommended nephrology guidelines in clinical practice\u003c\/li\u003e\n\u003cli\u003eExplain the differential diagnosis of complex clinical presentations of patients with renal disorders\u003c\/li\u003e\n\u003cli\u003eIdentify\/integrate current therapeutic options for specific renal disorders\u003c\/li\u003e\n\u003cli\u003eReview and interpret up-to-date literature relevant to clinical practice\u003c\/li\u003e\n\u003cli\u003eDescribe pathophysiological mechanisms as they apply to management of renal disease\u003c\/li\u003e\n\u003cli\u003eSynthesize teachings to better performance on the ABIM Nephrology certification\/recertification examinations\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eTarget Audience\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003eThe target audience for the \u003cem\u003eIntensive Review of Nephrology\u003c\/em\u003e course is clinical and academic nephrologists, internists, pediatricians, and primary care physicians\/trainees preparing for ABIM nephrology certification\/recertification examinations and\/or seeking a comprehensive update in renal medicine and its subspecialties.\u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003e+ Topics:\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003e01 Renal Physiology for the Boards – Melanie P. Hoenig, MD.mp4\u003cbr\u003e02 Basic Concepts of Immunology in Autoimmune Kidney Disease – Ramon G. Bonegio, MD.mp4\u003cbr\u003e03 Question and Answer Session – Faculty.mp4\u003cbr\u003e04 Renal Pathology in 2024 – Part 1 – Nephritic Conditions – Helmut G. Rennke, MD.mp4\u003cbr\u003e05 Renal Pathology in 2024 – Part 2 – Nephritic Syndrome – Astrid Weins, MD, PhD.mp4\u003cbr\u003e06 Urine Sediment Analysis – Martina M. McGrath, MD.mp4\u003cbr\u003e07 Question and Answer Session – Faculty.mp4\u003cbr\u003e08 Pathogenesis, Diagnosis, and Treatment of IgA Nephropathy – Gerald B. Appel, MD.mp4\u003cbr\u003e09 Metabolic Management of Kidney Stones – Gary C. Curhan, MD, ScD.mp4\u003cbr\u003e10 Impact of the Race Multiplier in the Estimated GFR Equation on African American CKD Care Delivery – Winfred W. Williams, Jr., MD.mp4\u003cbr\u003e11 Question and Answer Session – Faculty.mp4\u003cbr\u003e12 Update on Lupus Nephritis – Gerald B. Appel, MD.mp4\u003cbr\u003e13 Membranous Nephropathy – Laurence H. Beck, Jr., MD, PhD.mp4\u003cbr\u003e14 Anemia Management – Update and Best Practices – Ajay K. Singh, MBBS, FRCP (UK), MBA.mp4\u003cbr\u003e15 Question and Answer Session – Faculty.mp4\u003cbr\u003e16 Acid-Base Disorders Part I – Anion Gap Metabolic Acidosis – Alan S.L. Yu, MB, BChir.mp4\u003cbr\u003e17 Acid-Base Disorders II – Non-Gap Acidosis and Metabolic Alkalosis – Alan S.L. Yu, MB, Bchir.mp4\u003cbr\u003e18 Question and Answer Session – Faculty.mp4\u003cbr\u003e19 Sodium Disorders – David B. Mount, MD, FRCP(C).mp4\u003cbr\u003e20 Potassium Disorders – David B. Mount, MD, FRCP(C).mp4\u003cbr\u003e21 Question and Answer Session – Faculty.mp4\u003cbr\u003e22 Important New Trials in Glomerular Disease – Saif A. Alenizi, MBChB, MPH.mp4\u003cbr\u003e23 Genetics and Kidney Disease – Friedhelm Hildebrandt, MD.mp4\u003cbr\u003e24 Update on Polycystic Kidney Disease – Cristian Riella, MD.mp4\u003cbr\u003e25 Question and Answer Session – Faculty.mp4\u003cbr\u003e26 Pediatric Nephrology – Michael J.G. Somers, MD.mp4\u003cbr\u003e27 Genetics – How to Integrate It into Practice – Ana Onuchic-Whitford, MD.mp4\u003cbr\u003e28 Vasculitis and ANCA – John L. Niles, MD.mp4\u003cbr\u003e29 Question and Answer Session – Faculty.mp4\u003cbr\u003e30 Why Do We Reject a Transplant – Jamil R. Azzi, MD.mp4\u003cbr\u003e31 Transplant Immunosuppression for the Boards – Brittany L. Schreiber, MD.mp4\u003cbr\u003e32 Question and Answer Session – Faculty.mp4\u003cbr\u003e33 Immunological Assessment Pre and Post Transplant – Melissa Y. Yeung, MD and Indira Guleria, PhD.mp4\u003cbr\u003e34 Early Post-Transplant Management – Anil K. Chandraker, MD.mp4\u003cbr\u003e35 Question and Answer Session – Faculty.mp4\u003cbr\u003e36 Evaluation of the Living Donor Candidate – Kassem Safa, MD.mp4\u003cbr\u003e37 Late Loss of the Kidney Transplant – John Y. Choi, MD.mp4\u003cbr\u003e38 Infections in Transplant Recipients – Sarah P. Hammond, MD.mp4\u003cbr\u003e39 Monitoring Kidney Transplant Patients – Beyond Creatinine – Jamil R. Azzi, MD.mp4\u003cbr\u003e40 Pre-Transplant Surgical Evaluation of Recipients – Saif A. Alenizi, MBChB, MPH.mp4\u003cbr\u003e41 Question and Answer Session – Faculty.mp4\u003cbr\u003e42 Poisonings and Intoxications – What a Nephrologist Needs to Know – Timothy B. Erickson, MD.mp4\u003cbr\u003e43 Late Post-Transplant Medical Complications – Leonardo V. Riella, MD, PhD.mp4\u003cbr\u003e44 Hemolytic Uremic Syndrome (HUS) and Thrombotic Thrombocytopenic Purpura (TTP) – Jean M. Francis, MD.mp4\u003cbr\u003e45 Geriatric Nephrology – Ernest I. Mandel, MD.mp4\u003cbr\u003e46 Question and Answer Session – Faculty.mp4\u003cbr\u003e47 Cardio-Renal Syndrome – Finnian R. McCausland, MB BCh, MMSc, FRCPI.mp4\u003cbr\u003e48 Management of Hypertension in CKD-Intensive or Standard Regimens – Richard J. Glassock, MD.mp4\u003cbr\u003e49 Question and Answer Session – Faculty.mp4\u003cbr\u003e50 Primary Aldosteronism – Anand Vaidya, MD, MMSc.mp4\u003cbr\u003e51 Keynote – Climate Change, Global Inequities, and the Kidney – Valerie A. Luyckx, MB BCh, MSc, PhD.mp4\u003cbr\u003e52 Liver and the Kidney – Andrew S. Allegretti, MD, MSc.mp4\u003cbr\u003e53 Question and Answer Session – Faculty.mp4\u003cbr\u003e54 Pathophysiology of Acute Kidney Injury – Joseph V. Bonventre, MD, PhD.mp4\u003cbr\u003e55 Acute Kidney Injury Syndromes – Alice M. Sheridan, MD.mp4\u003cbr\u003e56 ICU Nephrology and Continuous Renal Replacement Therapies – David J.R. Steele, MB BCh.mp4\u003cbr\u003e57 Question and Answer Session – Faculty.mp4\u003cbr\u003e58 Acute Kidney Injury in Cancer – Raad B. Chowdhury, MD, FASN.mp4\u003cbr\u003e59 Dysproteinemia for the Nephrologist – Raad Chowdhury, MD, FASN.mp4\u003cbr\u003e60 Therapy of Focal and Segmental Glomerulosclerosis (FSGS) Lesions in 2024 – Richard J. Glassock, MD.mp4\u003cbr\u003e61 Pathophysiology and Treatment of Diabetic Kidney Disease – Gearoid M. McMahon, MB BCh.mp4\u003cbr\u003e62 APOL1 and Kidney Disease – Opeyemi Olabisi, MD, PhD.mp4\u003cbr\u003e63 Question and Answer Session – Faculty.mp4\u003cbr\u003e64 Patient Perspective – Dialysis Dosing – Moderators – J. Kevin Tucker, MD and Diane Goodwin, RN, BSN, CNN, Dialysis Patients Daphne Rhodes and Vanessa Evans.mp4\u003cbr\u003e65 Chronic Kidney Disease – Mineral and Bone Disease – David Bushinsky, MD.mp4\u003cbr\u003e66 Question and Answer Session – Faculty.mp4\u003cbr\u003e67 Dialysis – A Case-Based Clinical Review and Update – J. Kevin Tucker, MD.mp4\u003cbr\u003e68 Pearls in Mineral and Bone Disease – David Bushinsky, MD.mp4\u003cbr\u003e69 Chronic Kidney Disease Epidemiology – Gearoid M. McMahon, MB BCh.mp4\u003cbr\u003e70 Question and Answer Session – Faculty.mp4\u003cbr\u003e71 Introduction to Peritoneal Dialysis – Joanne M. Bargman, MD, FRCPC.mp4\u003cbr\u003e72 Complications of Peritoneal Dialysis – Joanne M. Bargman, MD, FRCPC.mp4\u003cbr\u003e73 Acute Kidney Injury Related to Immune Checkpoint Inhibitors – Shruti Gupta, MD, MPH.mp4\u003cbr\u003e74 Question and Answer Session – Faculty.mp4\u003cbr\u003e75 Mesoamerican Nephropathy – Ricardo Correa-Rotter, MD.mp4\u003cbr\u003e76 Ultrasound for the Clinical Nephrologist – Adina S. Voiculescu, MD.mp4\u003cbr\u003e77 Dialysis Vascular Access – Assessment and Complications – Dirk M. Hentschel, MD.mp4\u003cbr\u003e78 Glomerulonephritis – Questions \u0026amp; Answers Session – Gerald B. Appel, MD.mp4\u003cbr\u003e79 Must-Know Clinical Images in Nephrology – Ajay K. Singh, MBBS, FRCP (UK), MBA.mp4\u003cbr\u003e80 Electrolytes and Acid-Base Practice for the Boards – Part 1 – Alan S.L. Yu, MB, Bchir.mp4\u003cbr\u003e81 Electrolytes and Acid-Base Practice for the Boards – Part 2 – Alan S.L. Yu, MB, Bchir.mp4\u003cbr\u003e82 Chronic Kidney Disease in the Community – Leveraging Resources Effectively, Lessons Learned from KDSAP – Li-Li Hsiao, MD, PhD, FACP.mp4\u003cbr\u003e83 COVID-19 Vaccination in Immunocompromised Patients – Ann E. Woolley, MD.mp4\u003cbr\u003e84 Update on Renovascular Disease – Joseph M. Garasic, MD.mp4\u003cbr\u003e85 Pre-Transplant Surgical Evaluation of Recipients – Sayeed Malek, MD, FACS.mp4\u003cbr\u003e86 Immunologic Basis of Kidney Disease – Vivek Kasinath, MD.mp4\u003cbr\u003e87 Use of Checkpoint Inhibitors in Kidney Transplant Recipients – Naoka Murakami, MD, PhD.mp4\u003cbr\u003e88 Interstitial Nephritis – Overview for the Boards – Julie M. Paik, MD, ScD, MPH.mp4\u003cbr\u003e89 Ethics in Nephrology – Valerie Luyckx, MB BCh, MSc, PhD.mp4\u003cbr\u003e90 Pregnancy and Renal Disease – Jessica Tangren, MD.mp4\u003cbr\u003e91 Transplant Cases – Board Review Practice – Melissa Y. Yeung, MD and Edgar L. Milford, Jr., MD.mp4\u003cbr\u003e92 Transplant Board Review – Anil K. Chandraker, MD.mp4\u003cbr\u003e93 Must-Know Board Zebras – Emily Robinson, MD, MPH.mp4\u003cbr\u003e94 Nephrology Board Review Practice 1 – Finnian R. McCausland, MB BCh, MMSc, FRCPI.mp4\u003cbr\u003e95 Nephrology Board Review Practice 2 – Gearoid M. McMahon, MB BCh.mp4\u003cbr\u003eQuestions.pdf\u003cbr\u003eSyllabus.pdf\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954442211426,"sku":"MED-AMB03624","price":38.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/Oakstone-Intensive-Review-of-Nephrology-2024.jpg?v=1779376853","url":"https:\/\/meducourse.com\/products\/intensive-review-of-nephrology-2024","provider":"Meducourse","version":"1.0","type":"link"}